Preparative Therapies Used for those with Fanconi's Anemia Undergoing Stem Cell Transplants and Subsequent Engraftment Rates

Author： Trigg Michael E.   Bond Robert  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.8, Iss.6, 2003-12, pp. : 397-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characterization of a hematopoietic stem cell with engraftment advantage

By Chen J.   Astle C.M.   Harrison D.E.  

Experimental Hematology, Vol. 28, Iss. 12, 2000-12 ,pp. : 1498-1498

Elsevier

Access to resources Recommend Favorite

Chemokine Contribution in Stem Cell Engraftment into the Infarcted Myocardium

By  

Current Stem Cell Research & Therapy, Vol. 8, Iss. 4, 2013-01 ,pp. : 278-283

Bentham Science Publishers

Access to resources Recommend Favorite

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

By Hicks C.   Wong R.   Manoharan A.   Kwan Y.  

Annals of Hematology, Vol. 86, Iss. 8, 2007-08 ,pp. : 591-598

Springer Publishing Company

Access to resources Recommend Favorite

Disease model: Fanconi anemia

By Wong J.C.Y.   Buchwald M.  

Trends in Molecular Medicine, Vol. 8, Iss. 3, 2002-03 ,pp. : 139-142

Elsevier

Access to resources Recommend Favorite

Fanconi anemia: Current management

By Kook Hoon  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 108-110

Maney Publishing

Access to resources Recommend Favorite